Literature DB >> 27385439

Fas apoptosis inhibitory molecules: more than death-receptor antagonists in the nervous system.

Laura Planells-Ferrer1,2,3, Jorge Urresti1,2,3, Elena Coccia1,2,3, Koen M O Galenkamp1,2,3, Isabel Calleja-Yagüe1,2,3, Joaquín López-Soriano1,2,3, Paulina Carriba1,2,3, Bruna Barneda-Zahonero4,5,6, Miguel F Segura7, Joan X Comella8,9,10.   

Abstract

The importance of death receptor (DR) signaling in embryonic development and physiological homeostasis is well established, as is the existence of several molecules that modulate DRs function, among them Fas Apoptotis Inhibitory Molecules. Although FAIM1, FAIM2, and FAIM3 inhibit Fas-induced cell death, they are not structurally related, nor do they share expression patterns. Moreover, they inhibit apoptosis through completely different mechanisms. FAIM1 and FAIM2 protect neurons from DR-induced apoptosis and are involved in neurite outgrowth and neuronal plasticity. FAIM1 inhibits Fas ligand- and tumor necrosis factor alpha-induced apoptosis by direct interaction with Fas receptor and through the stabilization of levels of X-linked inhibitor of apoptosis protein, a potent anti-apoptotic protein that inhibits caspases. Low FAIM1 levels are found in Alzheimer's disease, thus sensitizing neurons to tumor necrosis factor alpha and prompting neuronal loss. FAIM2 protects from Fas by direct interaction with Fas receptor, as well as by modulating calcium release at the endoplasmic reticulum through interaction with Bcl-xL. Several studies prove the role of FAIM2 in diseases of the nervous system, such as ischemia, bacterial meningitis, and neuroblastoma. The less characterized member of the FAIM family is FAIM3, which is expressed in tissues of the digestive and urinary tracts, bone marrow and testes, and restricted to the cerebellum in the nervous system. FAIM3 protects against DR-induced apoptosis by inducing the expression of other DR-antagonists such as CFLAR or through the interaction with the DR-adaptor protein Fas-associated via death domain. FAIM3 null mouse models reveal this protein as an important mediator of inflammatory autoimmune responses such as those triggered in autoimmune encephalomyelitis. Given the differences between FAIMs and the variety of processes in which they are involved, here we sought to provide a concise review about these molecules and their roles in the physiology and pathology of the nervous system. Even though they share name and inhibit Fas-induced cell death, Fas apoptotic inhibitory molecules (FAIMs) are not structurally related and inhibit apoptosis through completely different mechanisms. In this review, we describe FAIM1, FAIM2, and FAIM3 functions in the nervous system, and their implication in diverse pathologies such as neurodegenerative disease, cancer, or autoimmune diseases.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  FAIM; TOSO; apoptosis; lifeguard; nervous system

Mesh:

Substances:

Year:  2016        PMID: 27385439     DOI: 10.1111/jnc.13729

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer.

Authors:  Kelin She; Hui Yan; Jun Huang; Huaping Zhou; Jianxing He
Journal:  Cell Prolif       Date:  2017-11-12       Impact factor: 6.831

2.  MicroRNA-128-3p Protects Mouse Against Cerebral Ischemia Through Reducing p38α Mitogen-Activated Protein Kinase Activity.

Authors:  Guochao Mao; Pengyu Ren; Gang Wang; Feng Yan; Yuelin Zhang
Journal:  J Mol Neurosci       Date:  2016-11-30       Impact factor: 3.444

3.  FAIM-S functions as a negative regulator of NF-κB pathway and blocks cell cycle progression in NSCLC cells.

Authors:  Pengcheng Wang; Wenze Xun; Tianyu Han; Zhujun Cheng
Journal:  Cell Cycle       Date:  2020-11-29       Impact factor: 4.534

4.  Functional characterization of zebrafish orthologs of the human Beta 3-Glucosyltransferase B3GLCT gene mutated in Peters Plus Syndrome.

Authors:  Eric Weh; Hideyuki Takeuchi; Sanaa Muheisen; Robert S Haltiwanger; Elena V Semina
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

Review 5.  Inflammation Resolution and the Induction of Granulocyte Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs.

Authors:  Jennifer A Cartwright; Christopher D Lucas; Adriano G Rossi
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

Review 6.  FAIM: An Antagonist of Fas-Killing and Beyond.

Authors:  Jianxin Huo; Shengli Xu; Kong-Peng Lam
Journal:  Cells       Date:  2019-06-04       Impact factor: 6.600

7.  Fas Apoptosis Inhibitory Molecule Blocks and Dissolves Pathological Amyloid-β Species.

Authors:  Hiroaki Kaku; Alexander V Ludlow; Michael F Gutknecht; Thomas L Rothstein
Journal:  Front Mol Neurosci       Date:  2021-12-14       Impact factor: 5.639

8.  FAIM2 Promotes Non-Small Cell Lung Cancer Cell Growth and Bone Metastasis by Activating the Wnt/β-Catenin Pathway.

Authors:  Kelin She; Wensheng Yang; Mengna Li; Wei Xiong; Ming Zhou
Journal:  Front Oncol       Date:  2021-09-09       Impact factor: 6.244

9.  Identification and characterization of new isoforms of human fas apoptotic inhibitory molecule (FAIM).

Authors:  Elena Coccia; Isabel Calleja-Yagüe; Laura Planells-Ferrer; Blanca Sanuy; Belen Sanz; Joaquin López-Soriano; Rana S Moubarak; Francina Munell; Bruna Barneda-Zahonero; Joan X Comella; M Jose Pérez-García
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

10.  FAIM Opposes Aggregation of Mutant SOD1 That Typifies Some Forms of Familial Amyotrophic Lateral Sclerosis.

Authors:  Hiroaki Kaku; Alexander V Ludlow; Michael F Gutknecht; Thomas L Rothstein
Journal:  Front Neurosci       Date:  2020-02-21       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.